| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |